Open Access

Implementing empagliflozin for HFpEF treatment in my practice.

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Session

About the speaker

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)
58 presentations
0 follower

3 more presentations in this session

Introduction and recap.

Speaker: Professor S. Anker (Berlin, DE)


What is the evidence for empagliflozin in HFpEF?

Speaker: Professor G. Rosano (London, GB)


Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)


Access the full session

SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF?

Speakers: Professor M. Boehm, Professor S. Anker, Professor G. Rosano, Professor S. Anker

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk